| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |